These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 24478816)
1. Absence of Genomic Qazi S; Ma H; Uckun FM Int J Mol Med Sci; 2013 Jul; 3(9):72-82. PubMed ID: 24478816 [TBL] [Abstract][Full Text] [Related]
2. Effect of IKZF1 deletions on signal transduction pathways in Philadelphia chromosome negative pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). van der Sligte NE; Scherpen FJ; Ter Elst A; Guryev V; van Leeuwen FN; de Bont ES Exp Hematol Oncol; 2015; 4():23. PubMed ID: 26269779 [TBL] [Abstract][Full Text] [Related]
3. [Significance of ikaros family zinc finger 1 deletion in pediatric B-acute lymphoblastic leukemia without reproducible cytogenetic abnormalities]. Liu X; Zhang L; Zou Y; Chang L; Wei W; Ruan M; Chen Y; Yang W; Chen X; Guo Y; Wang S; Liu T; Zhang J; Liu F; Qi B; An W; Zhu X Zhonghua Er Ke Za Zhi; 2016 Feb; 54(2):126-30. PubMed ID: 26875463 [TBL] [Abstract][Full Text] [Related]
4. Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia". Palmi C; Lana T; Silvestri D; Savino A; Kronnie GT; Conter V; Basso G; Biondi A; Valsecchi MG; Cazzaniga G Haematologica; 2013 Dec; 98(12):e164-5. PubMed ID: 24323991 [No Abstract] [Full Text] [Related]
5. RAS pathway mutation is an added-value biomarker in pediatric Philadelphia-negative B-cell acute lymphoblastic leukemia with IKZF1 deletions. Huang YJ; Liu HC; Jaing TH; Wu KH; Wang SC; Yen HJ; Hsiao CC; Chen SH; Lin PC; Yeh TC; Sheen JM; Chen YC; Chang TK; Huang FL; Chao YH; Hou JY; Yang CP; Lin TH; Shih LY Pediatr Blood Cancer; 2021 Apr; 68(4):e28899. PubMed ID: 33522704 [TBL] [Abstract][Full Text] [Related]
7. High frequency of IKZF1 genetic alterations in adult patients with B-cell acute lymphoblastic leukemia. Tokunaga K; Yamaguchi S; Iwanaga E; Nanri T; Shimomura T; Suzushima H; Mitsuya H; Asou N Eur J Haematol; 2013 Sep; 91(3):201-208. PubMed ID: 23751147 [TBL] [Abstract][Full Text] [Related]
8. What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia? Palmi C; Valsecchi MG; Longinotti G; Silvestri D; Carrino V; Conter V; Basso G; Biondi A; Kronnie GT; Cazzaniga G Haematologica; 2013 Aug; 98(8):1226-31. PubMed ID: 23585525 [TBL] [Abstract][Full Text] [Related]
9. IKZF1 Deletions as a Prognostic Factor in Costa Rican Patients With Pediatric B-Cell Acute Lymphoblastic Leukemia. Granados-Zamora M; Chaves-Herrera K; Morera-Araya E; Granados-Alfaro P; Valverde-Muñoz K; Soto-Herrera G; Santamaría-Quesada C J Pediatr Hematol Oncol; 2020 Aug; 42(6):e401-e406. PubMed ID: 32324698 [TBL] [Abstract][Full Text] [Related]
10. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report. Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381 [TBL] [Abstract][Full Text] [Related]
11. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients. Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924 [TBL] [Abstract][Full Text] [Related]
12. Clinical impacts of copy number variations in B-cell differentiation and cell cycle control genes in pediatric B-cell acute lymphoblastic leukemia: a single centre experience. Crepinsek K; Marinsek G; Kavcic M; Prelog T; Kitanovski L; Jazbec J; Debeljak M Radiol Oncol; 2021 Dec; 56(1):92-101. PubMed ID: 34957727 [TBL] [Abstract][Full Text] [Related]
13. Loss-of-function but not dominant-negative intragenic Kobitzsch B; Gökbuget N; Schwartz S; Reinhardt R; Brüggemann M; Viardot A; Wäsch R; Starck M; Thiel E; Hoelzer D; Burmeister T Haematologica; 2017 Oct; 102(10):1739-1747. PubMed ID: 28751559 [TBL] [Abstract][Full Text] [Related]
14. Clinical value of RAG1 expression and IKZF1 deletions in Philadelphia negative pediatric B cell precursor acute lymphoblastic leukemia. Aref S; Khaled N; Menshawy NE; Sabry M; Agder MA Pediatr Hematol Oncol; 2020 Aug; 37(5):380-389. PubMed ID: 32644850 [TBL] [Abstract][Full Text] [Related]
15. Incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia. Qazi S; Uckun FM Haematologica; 2013 Dec; 98(12):e151-2. PubMed ID: 24323986 [No Abstract] [Full Text] [Related]
16. Developmental origins and impact of BCR-ABL1 fusion and IKZF1 deletions in monozygotic twins with Ph+ acute lymphoblastic leukemia. Cazzaniga G; van Delft FW; Lo Nigro L; Ford AM; Score J; Iacobucci I; Mirabile E; Taj M; Colman SM; Biondi A; Greaves M Blood; 2011 Nov; 118(20):5559-64. PubMed ID: 21960589 [TBL] [Abstract][Full Text] [Related]
18. Constitutive function of the Ikaros transcription factor in primary leukemia cells from pediatric newly diagnosed high-risk and relapsed B-precursor ALL patients. Uckun FM; Ma H; Ishkhanian R; Arellano M; Shahidzadeh A; Termuhlen A; Gaynon PS; Qazi S PLoS One; 2013; 8(11):e80732. PubMed ID: 24278314 [TBL] [Abstract][Full Text] [Related]
19. IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan. Asai D; Imamura T; Suenobu S; Saito A; Hasegawa D; Deguchi T; Hashii Y; Matsumoto K; Kawasaki H; Hori H; Iguchi A; Kosaka Y; Kato K; Horibe K; Yumura-Yagi K; Hara J; Oda M; Cancer Med; 2013 Jun; 2(3):412-9. PubMed ID: 23930217 [TBL] [Abstract][Full Text] [Related]
20. IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol. Dörge P; Meissner B; Zimmermann M; Möricke A; Schrauder A; Bouquin JP; Schewe D; Harbott J; Teigler-Schlegel A; Ratei R; Ludwig WD; Koehler R; Bartram CR; Schrappe M; Stanulla M; Cario G Haematologica; 2013 Mar; 98(3):428-32. PubMed ID: 22875627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]